Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999–2025 - Report - MDSpire

Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999–2025

  • By

  • Muhammad Atif Mazhar

  • Abdal Ahmad

  • Vishan Das

  • Danyal Ahmad

  • Kaneez Fatima

  • Muhammad Mukhlis

  • Eshal Atif

  • Zubair Ahmed

  • Sadia Qazi

  • July 16, 2026

Share

Clinical Report: Mortality Trends and Inequities Related to Atherosclerotic Cardiovascular Disease and Stroke Among Adults in the U.S., 1999–2025

Background

Atherosclerotic cardiovascular disease and stroke are leading causes of death in the United States, with overlapping risk factors and significant public health implications. Recent analyses indicate that while mortality rates have declined, this progress has been inconsistent, particularly among younger adults and marginalized populations.

Data Highlights

YearAge-Adjusted Mortality Rate (AAMR) per 100,000
199926.82
202510.91

Key Findings

  • Overall average AAMR for ASCVD and stroke-related conditions was 15.01 per 100,000.
  • Mortality rates declined from 26.82 in 1999 to 10.91 per 100,000 in 2025, with an annual percentage change (AAPC) of 3.53% (p < 0.001).
  • A borderline significant increase in mortality was observed from 2018 to 2021 (APC: 6.06%; p = 0.050).
  • Mortality burden was higher among men, older adults, Black individuals, and residents of the South.
  • Adults aged 2544 years showed a significant increase in mortality rates after 2015.

Clinical Implications

Healthcare professionals should be aware of the persistent disparities in ASCVD and stroke mortality, particularly among younger adults and marginalized populations. Enhanced prevention strategies are necessary to address these inequities and improve outcomes.

Conclusion

While there has been a significant decline in mortality related to ASCVD and stroke from 1999 to 2025, the observed disparities and recent increases during the pandemic period are noted.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Author(s)/Org, Source, Year -- Title
  6. Author(s)/Org, Source, Year -- Title
  7. Author(s)/Org, Source, Year -- Title
  8. Author(s)/Org, Source, Year -- Title
  9. 2026 Heart Disease and Stroke Statistics - Professional Heart Daily | American Heart Association
  10. How Have CVD Mortality Trends in the US Changed Since 1999? - American College of Cardiology
  11. Vital Statistics Rapid Release, Number 039 (September 2025)
  12. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association
  13. First-ever clinical guideline issued for cardiovascular-kidney-metabolic (CKM) syndrome | American Heart Association
  14. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association | Stroke
  15. Endovascular thrombectomy in acute stroke with a large ischemic core: A systematic review and meta-analysis of randomized controlled trials - PubMed
  16. Safety and efficacy of intravenous tenecteplase in patients with acute ischemic stroke in the extended time window: an updated meta-analysis | European Journal of Clinical Pharmacology | Springer Nature Link
  17. Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients - PubMed
  18. Social and Environmental Determinants of Stroke Functional Outcome and Strategies to Reduce Inequities: A Scientific Statement From the American Heart Association - PubMed

Original Source(s)

Related Content